HealthEquity, Inc. (NASDAQ:HQY – Get Rating) Director Debra Charlotte Mccowan sold 4,225 shares of the firm's stock in a transaction dated Tuesday, September 27th. The shares were sold at an average price of $70.91, for a total transaction of $299,594.75. Following the transaction, the director now owns 7,072 shares of the company's stock, valued at approximately $501,475.52. The transaction was disclosed in a document filed with the SEC, which is available at this link.

HealthEquity Stock Performance

HQY stock opened at $67.17 on Friday. The stock has a market cap of $5.68 billion, a P/E ratio of -90.77, a P/E/G ratio of 3.82 and a beta of 0.90. The firm has a 50 day simple moving average of $64.40 and a 200 day simple moving average of $63.50. HealthEquity, Inc. has a 52 week low of $36.81 and a 52 week high of $74.04.

HealthEquity (NASDAQ:HQY – Get Rating) last issued its quarterly earnings data on Tuesday, September 6th. The company reported $0.33 earnings per share for the quarter, meeting the consensus estimate of $0.33. HealthEquity had a negative net margin of 7.82% and a positive return on equity of 2.86%. During the same quarter last year, the firm earned $0.21 EPS. Sell-side analysts predict that HealthEquity, Inc. will post 0.69 EPS for the current year.

Hedge Funds Weigh In On HealthEquity

Wall Street Analysts Forecast Growth

Several research analysts have commented on HQY shares. Barrington Research raised their target price on shares of HealthEquity from $70.00 to $75.00 in a report on Tuesday, June 7th. KeyCorp started coverage on shares of HealthEquity in a report on Thursday, September 15th. They issued an "overweight" rating and a $85.00 target price for the company. Robert W. Baird raised their target price on shares of HealthEquity from $47.00 to $67.00 and gave the stock a "neutral" rating in a report on Wednesday, September 7th. Deutsche Bank Aktiengesellschaft raised their target price on shares of HealthEquity from $67.00 to $68.00 and gave the stock a "buy" rating in a report on Thursday, September 8th. Finally, Wells Fargo & Company raised their target price on shares of HealthEquity from $95.00 to $100.00 and gave the stock an "overweight" rating in a report on Tuesday, September 13th. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $75.36.

HealthEquity Company Profile

(Get Rating)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Further Reading

• Get a free copy of the StockNews.com research report on HealthEquity (HQY)
• EV Battery Maker Freyr Set For Major Global Expansion
• MarketBeat: Week in Review 9/26 – 9/30
• This Is A Memorable Time To Buy Into Micron Technology
• Declining Profits Challenge the CarMax Value Proposition
• Let Paychex Stock Work Hard For You

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.